Suspected Heparin-Induced Thrombocytopenia Terminated Phase 4 Trials for Desirudin (DB11095)

IndicationStatusPhase
DBCOND0042408 (Suspected Heparin-Induced Thrombocytopenia)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00787332A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis SyndromePrevention